Peer Review History
| Original SubmissionAugust 27, 2020 |
|---|
|
PONE-D-20-26921 Dynamical SPQEIR model assesses the effectiveness of non-pharmaceutical interventions against COVID-19 epidemic outbreaks PLOS ONE Dear Dr. Proverbio, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In particular, Referee #2 has raised a number of critical remarks regarding the model structure and the statistical analysis that require careful consideration. Please submit your revised manuscript by Jan 30 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Michele Tizzoni Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The paper introduces in the SEIR model 3 different types of non-pharmaceutical interventions i.e. social distancing, quarantine of exposed individuals and generalized lock-down. After the outbreak of COVID pandemic several papers have been published in this direction e.g. Das et al. medRXIV https://doi.org/10.1101/2020.06.04.20122580; Tomas de-Camino-Beck. medRXIV https://doi.org/10.1101/2020.05.19.20106492; Perkins et al. Bulletin of Mathematical Biology 82, 118 (2020); Lai et al. Nature volume 585, 410–413 (2020); Alrrashed et al Informatics in Medicine Unlocked 20, 100420 (2020) and also for the SIR model where quarantine is directly introduced on the infected nodes: Anand et al. Transactions of the Indian National Academy of Engineering 5, 141–148 (2020) Giordano et al. Nature Medicine 26, 855–860 (2020) Mancastroppa et al. Phys. Rev. E 102, 020301(R) (2020) Many other papers have been recently published or submitted. In these models often several aspects are taken into account which are overlooked in the present paper e.g. hospitalization, asymptomatic individuals, heterogeneous behavior of the individuals. The authors should explain what is the main advance with respect the vast recent literature. In this respect, the authors consider the simultaneous adoption of three different kinds of measures, however it is not clear in the paper what is the main advantages of introducing this modelization. In particular which are the different effects due to the three strategy of containment? E.g. when you consider the fit of datasets the use of a single strategy (i.e. social distancing) provides a very similar fit of the case where the synergy of the different strategies is considered; also the improvement in the X^2 is very small. So it is not clear what is the advantage of adopting the different strategies, in the description of non-pharmaceutical interventions. In summary the paper introduces a model with a description of three types of non-pharmaceutical interventions, this interventions have been already introduced in different papers even if with some differences. In this context, from a theoretical point of view the authors do not evidence any peculiar or interesting effect due to the presence of these three terms; while a comparison with datasets does not show any advantages in interpretations of the epidemic evolution in the different countries. In this perspective I think that the paper is not suitable for publication without a significant improvement. Another very important remark is about the model for a generalized lock-down. In your approach only susceptible nodes are isolated in the state P while I expect that a fraction of the whole population in a lock-down is isolated; in particular I expect that the sudden isolation of infected and exposed individuals should have a larger effect than the isolation of susceptible ones. Moreover I think that the process should be described only by the approach in figure 4 i.e. a sudden isolation of a large number of individuals which remain isolated during the whole period of non-pharmaceutical interventions; while other individuals do not self isolates (e.g. they do an essential job), so that after the quick self isolation mu is restored to 0. On the other hand, a self isolation with constant rate, in the whole period of intervention seems to be very unlikely. An even a similar and simpler model of a generalized lock down could be at the beginning of the intervention an instantaneous isolation in the state P of a fraction of individuals (independently of their states). Therefore, I think that the different scenarios and the data fitting should take into account only the approach in figure 4 (clearly with possible different fraction of people that self isolate). Reviewer #2: REVIEWER COMMENTS TO AUTHORS Referee report: PONE-D-20-26921 Evaluation The paper has a number of shortcomings, and would require a much deeper discussion of several parts (see my main points). Also, the epidemiological language should be improved in many points. Some cited papers are weak. Therefore, the authors should (i) do an effort to (substantially) amend their paper according to the indications reported below, but especially (ii) put into evidence their findings that are of main epidemiological interest, particularly in relation to the insights that the adopted modeling framework would provide in relation to the understanding of COVID-19 control. Main points The proposed SPQEIR model is quite restrictive in its formulation and therefore the underlying hypotheses should be carefully discussed. First, P individuals are – according to the stated hypotheses - fully protected, which corresponds to full segregation forever i.e., during the entire history of intervention measures. But measures aimed at confining susceptible people hardly can go beyond home confinement, and there is strong evidence that – during lockdowns - much COVID transmission occurred within households (especially during the first wave). Pairwise, also removed E individuals are fully inactivated in the SPEIR. Also, this should be discussed carefully. Moreover, as E individuals can be removed mostly by way of tracing, it is not clear to me why you do not allow a pairwise option for I individuals (e.g. asymptomatic or pauci-symptomatic) by the same mechanism. Last, I understand screening and isolation of actively infected individuals is incorporated into removal (L99), which is an option. However, did you handle your removal rate to account for this (perhaps I didn’t note details)? L141 “We fit the model to the official number of currently infected (active) cases, for each considered country.” The authors are surely aware that published numbers of currently infectious cases poorly represent true infectious cases. So, this should at least be discussed more carefully. Moreover, this information risks of being severely biased when you aim at making comparisons between different countries – especially during the first wave - because it reflects the inter-country differences in testing and tracing, making comparisons unreliable. L>140. Fitting procedures. The authors adopted a nonlinear least squares procedure citing a rather old textbook whereas the basic statistics of epidemic data has progressed dramatically in the last twenty years, first of all maximum likelihood techniques. For example, I do not understand how the quantity in (3) can be used to document the improvement in fit compared to the baseline model. L83 “the time T passed until no new infections occur”, this is quite wrong at least as far as your model is a deterministic one, as I understand it is. In the practice of simulation this does not need to be a problem (and indeed you acknowledge this at a later stage), but the sentence should be modified. L119, the effective reproduction number is not explicit in the SIR model, because the susceptible fraction is not explicit. Therefore, the formula drawn from ref [26] is an approximation. The problem is that it is far from being general and rests on a number of hypotheses, which I find somewhat naive. This also holds for eq (1). I noted that even in the cited paper [26] the formula is given without a justification. The formula trivially holds if you assume that the removal by segregation of the susceptible population occurs rapidly, that is before the susceptible population is sufficiently depleted. In this case S(t) = Nexp(-\\�t), so that if you additionally assume that \\�t is small (which contradicts that segregation occurs fast) and resort to the linear approximation of the exponential function you arrive to the point. Anyhow, is this relevant for this paper? On top, I recommend to avoid to cite whatever paper appeared in this epoch because the quality is not necessarily good (sometimes poor) and may induce errors in readers. Legends of simulation exercises are scanty and should be improved. Other points > L34, “homogeneous propagation media” is naïve for most readers of the > Journal; as epidemiologists we speak of “a homogeneously mixing > population” which is a nowadays somewhat universally agreed > terminology. IBM models are not continuous but discrete models (due to their very structure of simulative models) L42, "likely" : socially active and at risk of infection L83 Clearly, the SEIR model by its I curve provides only a very indirect measure of the pressure on PH system (instead represented by ICU and hospitals occupancy). Even more so for the economic system. This should be discussed. L112 “resulting in the effective reproduction number”, In epidemiology the effective reproduction number deals with a situation where the susceptible proportion is depleted below one, as you correctly say in the subsequent line. Suggest to rephrase. L126 “We use mean values etc”, please clarify L129 “with conservation of the total number of individuals, meaning N’ = 0”, the argument goes the other way round, your system fulfills N’=0 implying that N is conserved. L86 “Mainstream suppression measures against the epidemic aim at flattening the curve of new infections”, replace “suppression “ by “mitigation” (flattening the epidemic curve is somewhat different from suppressing) L161 “comparative information analysis” this is not an agree terminology Minor points I suggest to delete “new” from the abstract and simply state: “an extended SEIR model including quarantine of susceptible an latently infected individuals” L8 “statistical methods allow for accurate characterization of the population's health state", stated like this is a bit trivial. L42, "likely" : socially active and at risk of infection L111 “repression” not appropriate L117 “physical reduction of a country's population” ? L182 I suggest to replace “mathematical” in the title with “Simulation”: it is a simulative analysis L189 “eradication time” inappropriate wording L194 Citation 32 is not appropriate. That paper considered a model with behavioral responses which are not included here. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-26921R1 Dynamical SPQEIR model assesses the effectiveness of non-pharmaceutical interventions against COVID-19 epidemic outbreaks PLOS ONE Dear Dr. Proverbio, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Reviewer #1 has raised some concerns that require an additional revision, in particular regarding the fit and the parameters of the model. Please submit your revised manuscript by Apr 09 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Michele Tizzoni Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors now clarify the main claim of their work: "We ultimately show that analogous containment levels of the infectious curve can be achieved by alternative synergies of non-pharmaceutical interventions." So the message of the paper now is clear and one can better evaluate the results. However several important points in my opinion still require improvement. - The authors claim that similar results can be obtained with different interventions. Figure 8 indeed provides similar curves for the first 4 scenarios where the value of the effective reproductive number is similar, while the evolution of scenarios 5 and 6 is different but these scenarios present a different effective R. In this perspective one could infer that scenarios with similar reproductive number display similar epidemic evolution, which is not surprising. Can you discuss this point? Moreover, you fit the data set using as fitting parameters only social distancing or considering all the parameters of the non-pharmaceutical interventions. Similar quality of the fittings are obtained, evidencing that different approachess can be adopted. However, the fit with the whole parameter set is very similar to the case where only social distancing is present (the parameters rho are close, while mu_ld chi and eta are very small). Therefore one could suppose that social distancing is the main intervention observed in the data. What happens e.g. if you consider in the fit only a lock down, which has been a common intervention in the first wave of COVID 19? You state that important correlations among the fitting parameters is observed. It should be interesting if you are able to show what is the region in the parameter space (rho,mu_ld, eta) where you obtain a nice fitting of the epidemic curves with a similar (small) value of chi^2. In this way one could compare the relevance of the different possible interventions. According to the previous hypothesis this region should correspond to a region at constant value of the reproductive number. - A small constant value of mu as modelling of protection in my opinion is not realistic. The case where a fraction of the population isolate in a small time well represent a lock down. While a constant rate of isolation during the whole epidemics it seems to me that do not represent a realistic non pharmaceutical intervention. While people should self isolate with a small constant rate? On the other hand, a constant mu could well represent vaccination which is not a pharmaceutical intervention. Moreover, the sentence: "In particular, μ = 0.01 d −1 ..... through isolation, this is unrealistic." seems to be in contrast with the large value of mu of figure 2. - In the lock down description where a large value of mu is activated for a small time to isolate quickly a finite fraction of the population I do not understand why only susceptible people are put into quarantine. I expect that a general measure as a lock down involves all the population including also exposed and infected individuals. Indeed the aim of a lock down is not only protection of the susceptible nodes but also isolation of potentially infected people. - 10 days from the onset of the first contagion is an arbitrary choice. The importance of an early adoption of measure of containment is a well known fact. Clearly 10 days belongs to such early adoption framework what happens if measures are taken after a longer time. The different strategies are still equivalent? - I do not understand the sentence: "However, we notice that values of ρ ' 0.3 or lower are more effective in mitigating the epidemic faster.?" clearly the smaller is rho the more is effective the measure to contain the epidemics, but what is the relevance of this comment? Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Piero Manfredi [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-20-26921R2 Dynamical SPQEIR model assesses the effectiveness of non-pharmaceutical interventions against COVID-19 epidemic outbreaks PLOS ONE Dear Dr. Proverbio, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please, in your revision address the minor issues raised by Reviewer 1. Please submit your revised manuscript by May 31 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Michele Tizzoni Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have answered to my previous questions and in general the paper is improved accordingly. However some points still require an improvement: My comment on the fact that during a lock down not only susceptible individuals are removed but also infected and exposed, has not been addressed clearly: "This is indeed an important point. From a modelling perspective, ........the combination of all out-flux parameters" If this means that during the short period of isolation of individuals (4 days) you set mu=mu_ld but also eta=mu_ld and xi=mu_ld so that also exposed and infected individuals are removed with the same rate? In my opinion this should be a correct approach: during a lock down the same fraction of S, E and I individuals are typically protected. If this is the case it should be explained, otherwise if you set only mu=mu_ld, the model isolate only susceptible individuals during a lock down which is not very likely and some explanations should be added. The authors introduce, in the supplementary, the analysis of the posterior probability distribution for different values of the parameters, evidencing that a nice fit of the experimental data is obtained in a wide region of the parameter set. This nice point answer to one of my previous question. However, I do not understand in figures 5,6 and 7 when you plot the probability as a function of two of the parameters how do you fix the value of the other parameters which are not consider in the plot. There is a typo at page 12: "Sec. ??" ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Dynamical SPQEIR model assesses the effectiveness of non-pharmaceutical interventions against COVID-19 epidemic outbreaks PONE-D-20-26921R3 Dear Dr. Proverbio, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Michele Tizzoni Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have answered to all my previous comments and now the article can be published on Plos One ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
| Formally Accepted |
|
PONE-D-20-26921R3 Dynamical SPQEIR model assesses the effectiveness of non-pharmaceutical interventions against COVID-19 epidemic outbreaks Dear Dr. Proverbio: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Michele Tizzoni Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .